BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 26720913)

  • 41. Trajectories of body mass index, from adolescence to older adulthood, and pancreatic cancer risk; a population-based case-control study in Ontario, Canada.
    De Rubeis V; Cotterchio M; Smith BT; Griffith LE; Borgida A; Gallinger S; Cleary S; Anderson LN
    Cancer Causes Control; 2019 Sep; 30(9):955-966. PubMed ID: 31230151
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Therapy-related leukemia and myelodysplastic syndrome in chronic lymphocytic leukemia.
    Robertson LE; Estey E; Kantarjian H; Koller C; O'Brien S; Brown B; Keating MJ
    Leukemia; 1994 Dec; 8(12):2047-51. PubMed ID: 7807993
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Higher body mass index is associated with better survival in patients with myelodysplastic syndromes.
    Jabbar KJ; Yin CC; Bueso-Ramos CE; Luthra R; Medeiros LJ; Zuo Z
    Leuk Res; 2018 Aug; 71():63-66. PubMed ID: 30015105
    [No Abstract]   [Full Text] [Related]  

  • 44. Association between mitochondrial DNA haplogroup and myelodysplastic syndromes.
    Poynter JN; Richardson M; Langer E; Hooten AJ; Roesler M; Hirsch B; Nguyen PL; Cioc A; Warlick E; Ross JA
    Genes Chromosomes Cancer; 2016 Sep; 55(9):688-93. PubMed ID: 27121678
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A high BMI is a risk factor in younger patients with de novo acute myelogenous leukemia.
    Crysandt M; Kramer M; Ehninger G; Bornhäuser M; Berdel WE; Serve H; Röllig C; Kaifie A; Jost E; Brummendorf TH; Wilop S
    Eur J Haematol; 2016 Jul; 97(1):17-24. PubMed ID: 26277604
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Preleukaemic clonal haemopoiesis and risk of therapy-related myeloid neoplasms: a case-control study.
    Takahashi K; Wang F; Kantarjian H; Doss D; Khanna K; Thompson E; Zhao L; Patel K; Neelapu S; Gumbs C; Bueso-Ramos C; DiNardo CD; Colla S; Ravandi F; Zhang J; Huang X; Wu X; Samaniego F; Garcia-Manero G; Futreal PA
    Lancet Oncol; 2017 Jan; 18(1):100-111. PubMed ID: 27923552
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Loss of the Y chromosome: an age-related or clonal phenomenon in acute myelogenous leukemia/myelodysplastic syndrome?
    Wong AK; Fang B; Zhang L; Guo X; Lee S; Schreck R
    Arch Pathol Lab Med; 2008 Aug; 132(8):1329-32. PubMed ID: 18684036
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Acute myeloid leukemia and myelodysplastic syndrome following breast cancer: increased frequency of other cancers and of cancers in multiple family members.
    Padmanabhan A; Baker JA; Zirpoli G; Sait SN; Ford LA; Moysich KB; Baer MR
    Leuk Res; 2008 Dec; 32(12):1820-3. PubMed ID: 18468682
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Genetic variants involved in oxidative stress, base excision repair, DNA methylation, and folate metabolism pathways influence myeloid neoplasias susceptibility and prognosis.
    Gonçalves AC; Alves R; Baldeiras I; Cortesão E; Carda JP; Branco CC; Oliveiros B; Loureiro L; Pereira A; Nascimento Costa JM; Sarmento-Ribeiro AB; Mota-Vieira L
    Mol Carcinog; 2017 Jan; 56(1):130-148. PubMed ID: 26950655
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The incidence, risk factors, and survival of acute myeloid leukemia secondary to myelodysplastic syndrome: A population-based study.
    Ye X; Chen D; Zheng Y; Wu C; Zhu X; Huang J
    Hematol Oncol; 2019 Oct; 37(4):438-446. PubMed ID: 31378958
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Therapy-related acute myeloid leukaemia and myelodysplastic syndrome in Victoria, Australia 2003-2014.
    Ong DM; Farrugia H; Wei A
    Intern Med J; 2018 Jul; 48(7):822-829. PubMed ID: 29236346
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Therapy-related myelodysplasia and acute myeloid leukemia.
    Bhatia S
    Semin Oncol; 2013 Dec; 40(6):666-75. PubMed ID: 24331189
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Recent improvement in completeness of incidence data on acute myeloid leukemia in US cancer registries.
    Polednak AP
    J Registry Manag; 2014; 41(2):77-84. PubMed ID: 25153013
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Association of Chemotherapy for Solid Tumors With Development of Therapy-Related Myelodysplastic Syndrome or Acute Myeloid Leukemia in the Modern Era.
    Morton LM; Dores GM; Schonfeld SJ; Linet MS; Sigel BS; Lam CJK; Tucker MA; Curtis RE
    JAMA Oncol; 2019 Mar; 5(3):318-325. PubMed ID: 30570657
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mesenchymal stromal cells from myelodysplastic and acute myeloid leukemia patients display in vitro reduced proliferative potential and similar capacity to support leukemia cell survival.
    Corradi G; Baldazzi C; Očadlíková D; Marconi G; Parisi S; Testoni N; Finelli C; Cavo M; Curti A; Ciciarello M
    Stem Cell Res Ther; 2018 Oct; 9(1):271. PubMed ID: 30359303
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A hospital-based case-control study of acute myeloid leukemia in Shanghai: analysis of personal characteristics, lifestyle and environmental risk factors by subtypes of the WHO classification.
    Wong O; Harris F; Yiying W; Hua F
    Regul Toxicol Pharmacol; 2009 Dec; 55(3):340-52. PubMed ID: 19703505
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Connect MDS/AML: design of the myelodysplastic syndromes and acute myeloid leukemia disease registry, a prospective observational cohort study.
    Steensma DP; Abedi M; Bejar R; Cogle CR; Foucar K; Garcia-Manero G; George TI; Grinblatt D; Komrokji R; Ma X; Maciejewski J; Pollyea DA; Savona MR; Scott B; Sekeres MA; Thompson MA; Swern AS; Nifenecker M; Sugrue MM; Erba H
    BMC Cancer; 2016 Aug; 16():652. PubMed ID: 27538433
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Risk of therapy-related secondary leukemia in Hodgkin lymphoma: the Stanford University experience over three generations of clinical trials.
    Koontz MZ; Horning SJ; Balise R; Greenberg PL; Rosenberg SA; Hoppe RT; Advani RH
    J Clin Oncol; 2013 Feb; 31(5):592-8. PubMed ID: 23295809
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Allo-HSCT for acute myeloid leukemia with myelodysplastic-related changes: a clinical analysis].
    Zhang HX; Pang AM; Chen X; Zhang RL; Zhai WH; Ma QL; Yang DL; Wei JL; He Y; Feng SZ; Han MZ; Jiang EL
    Zhonghua Xue Ye Xue Za Zhi; 2021 Oct; 42(10):814-822. PubMed ID: 34788920
    [No Abstract]   [Full Text] [Related]  

  • 60. Genetic predisposition to myelodysplastic syndrome and acute myeloid leukemia in children and young adults.
    Babushok DV; Bessler M; Olson TS
    Leuk Lymphoma; 2016; 57(3):520-36. PubMed ID: 26693794
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.